Evidence map›Paper›PMID 25244520›Full record

ReviewPLoS medicine2014

Financial risk protection and universal health coverage: evidence and measurement challenges.

Priyanka Saksena, Justine Hsu, David B Evans

Abstract readReview
In one paragraph

Review in PLoS medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 140 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
140citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

140 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Article
  8. The Dynamics of Hospitalization Expenses and Health Insurance: A Finite Mixture Model Approach.The European journal of health economics : HEPAC : health economics in prevention and care · 2026
    Article
  9. Article
  10. Economic burden of knee replacement, a case of Bushehr, Iran in 2023-2024.Cost effectiveness and resource allocation : C/E · 2026
    Article
  11. Article
  12. Contribution of Medication Expenditures to Catastrophic Health Expenditures in Iran: An Inequality Analysis.Journal of preventive medicine and public health = Yebang Uihakhoe chi · 2026
    Article
  13. Association between time to treatment and financial toxicity among women with breast cancer in Ethiopia: a multicentre study in a low-resource setting.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

80 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Priyanka SaksenaDepartment of Health Systems Governance and Financing, World Health Organization, Geneva, Switzerland; Swiss Tropical and Public Health Institute, University of Basel, Basel Switzerland.
Justine HsuDepartment of Health Systems Governance and Financing, World Health Organization, Geneva, Switzerland.
David B EvansDepartment of Health Systems Governance and Financing, World Health Organization, Geneva, Switzerland.

Funding

World Health Organization 001
6 · The paper itself

Abstract

Financial risk protection is a key component of universal health coverage (UHC), which is defined as access to all needed quality health services without financial hardship. As part of the PLOS Medicine Collection on measurement of UHC, the aim of this paper is to examine and to compare and contrast existing measures of financial risk protection. The paper presents the rationale behind the methodologies for measuring financial risk protection and how this relates to UHC as well as some empirical examples of the types of measures. Additionally, the specific challenges related to monitoring inequalities in financial risk protection are discussed. The paper then goes on to examine and document the practical challenges associated with measurement of financial risk protection. This paper summarizes current thinking on the area of financial risk protection, provides novel insights, and suggests future developments that could be valuable in the context of monitoring progress towards UHC.

Indexed as

Health ExpendituresHealth Care ReformHumansRiskRisk Sharing, FinancialSocioeconomic FactorsUniversal Health Insurance

Identifiers

PMID25244520
PMCPMC4171370

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.